Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RELA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RELA is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, therapeutic target. Associated with Aging, Als, Alzheimer. Connected to 379 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | NF |
| Full Name | κB p65 Protein |
| Aliases | RELA |
| Function | Nf Κb P105 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. |
| GeneCards | NF |
| Human Protein Atlas | NF |
| Associated Diseases | Aging, Als, Cancer, Glioblastoma, Hepatitis, Inflammation |
| Known Drugs/Compounds | RESVERATROL |
| Interactions | AKT, AKT1, ALZHEIMER, ALZHEIMER DISEASE, AMYLOID, AND |
| KG Connections | 752 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
RELA["RELA"]
RELA -->|"activates"| Cancer["Cancer"]
RELA -->|"activates"| Inflammation["Inflammation"]
RELA -->|"activates"| Aging["Aging"]
RELA -->|"activates"| Ms["Ms"]
RELA -->|"activates"| Carcinoma["Carcinoma"]
RELA -->|"activates"| Tumor["Tumor"]
RELA -->|"interacts"| Als["Als"]
NRF2["NRF2"] -->|"inhibits"| RELA
P38["P38"] -->|"activates"| RELA
MAP1LC3["MAP1LC3"] -->|"activates"| RELA
IL1B["IL1B"] -->|"activates"| RELA
PRDX1["PRDX1"] -->|"activates"| RELA
TRAF6["TRAF6"] -->|"activates"| RELA
CHUK["CHUK"] -->|"activates"| RELA
PRDX6["PRDX6"] -->|"activates"| RELA| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:RELA | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Senescence-Associated Secretory Phenotype | promotes | phenotype | 0.95 |
| Inflammation | activates | disease | 0.95 |
| MIR125B | upregulates | gene | 0.90 |
| YY1 | activates | gene | 0.90 |
| Nuclear Translocation | involved_in | process | 0.90 |
| CANCER | activates | gene | 0.90 |
| Cancer | activates | disease | 0.85 |
| Als | interacts_with | disease | 0.85 |
| Als | expressed_in | disease | 0.85 |
| Als | activates | disease | 0.85 |
| Osteoclast Differentiation | regulates | process | 0.85 |
| Tumor | activates | disease | 0.85 |
| MIR125B | regulates | biomarker | 0.85 |
| MIR9 | regulates | biomarker | 0.80 |
| Nf-Κb | interacts_with | pathway | 0.80 |
| Cancer | therapeutic_target | disease | 0.75 |
| Carcinoma | activates | disease | 0.75 |
| Inflammation | regulates | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Mapk | therapeutic_target | pathway | 0.70 |
| ISCHEMIA | causes | disease | 0.70 |
| Nf-Κb | expressed_in | pathway | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| ISCHEMIA | modifies | disease | 0.70 |
| NEURONS | protects_against | cell_type | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Nf-Κb | regulates | pathway | 0.70 |
| Nf-Κb | activates | pathway | 0.70 |
| Nf-Κb | therapeutic_target | pathway | 0.70 |
| Ms | inhibits | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Hypertension | therapeutic_target | disease | 0.65 |
| ISCHEMIA | phosphorylates | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Obesity | therapeutic_target | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| NEURON | interacts_with | cell_type | 0.65 |
| Als | regulates | disease | 0.65 |
| Lymphoma | regulates | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Atherosclerosis | interacts_with | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:RELA | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| IKBKG | phosphorylates | gene | 0.90 |
| NFKBIA | regulates | protein | 0.90 |
| Lapiferin | downregulates | compound | 0.90 |
| Riboflavin | suppresses | drug | 0.87 |
| Scutellarein | downregulates | compound | 0.85 |
| IKBA | inhibits | protein | 0.85 |
| TNF | therapeutic_target | gene | 0.70 |
| NF-ΚB | therapeutic_target | gene | 0.70 |
| AKT1 | therapeutic_target | gene | 0.70 |
| STAT3 | interacts_with | gene | 0.70 |
| NRF2 | inhibits | protein | 0.70 |
| RESVERATROL | treats | drug | 0.70 |
| INFLAMMATION | regulates | gene | 0.70 |
| NF-ΚB | interacts_with | gene | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| TP53 | therapeutic_target | gene | 0.70 |
| ALS | treats | disease | 0.70 |
| MYC | regulates | gene | 0.65 |
| MITOPHAGY | inhibits | phenotype | 0.65 |
| ROS | inhibits | phenotype | 0.65 |
| NEURODEGENERATION | regulates | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 0.60 |
| MIRNAS | therapeutic_target | gene | 0.60 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| ERBB2 | therapeutic_target | gene | 0.60 |
| HIF | therapeutic_target | gene | 0.60 |
| AND | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| PYROPTOSIS | activates | gene | 0.60 |
| HUB GENES | associated_with | gene | 0.60 |
| MIRNAS | activates | gene | 0.60 |
| MIR-155 | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| CCND1 | activates | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| STROKE | therapeutic_target | gene | 0.60 |
| IL-17 | therapeutic_target | gene | 0.60 |
| C-JUN | regulates | gene | 0.60 |
| MALAT1 | interacts_with | gene | 0.60 |
| P2RX3 | regulates | gene | 0.60 |
| NF-ΚB | regulates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning RELA in their description or question text
Score: 0.520 · neurodegeneration · 2026-04-21
## Mechanistic Overview HDAC1/2 Complex Restoration Corrects Age-Related Histone Hypoacetylation starts from the claim t
Score: 0.510 · neurodegeneration · 2026-04-21
## Mechanistic Overview Lamin B1 Restoration Prevents Age-Related Nuclear Lamina Compromise starts from the claim that m
Score: 0.440 · neurodegeneration · 2026-04-21
## Mechanistic Overview DNA Hypomethylation at P2RY12 Promoter Correlates with Disease Progression starts from the claim
Score: 0.362 · Alzheimer's disease · 2026-04-23
## Mechanistic Overview Age-related neuroinflammation mimics early Alzheimer's disease pathology starts from the claim t